Veterinarian Elizabeth Rozanski is leading a clinical trial at Tufts University's School of Veterinary Medicine of a treatment for idiopathic pulmonary fibrosis, a lung disease that affects West Highland terriers and other breeds, as well as people. The treatment, sobetirome, was developed to reduce cholesterol and works like a thyroid hormone in animal models of pulmonary fibrosis, and Dr. Rozanski is partnering with Yale University School of Medicine physician Naftali Kaminski on the study.
Sign up for FBR SmartBrief
Biomedical Research News
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.